AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
LYON, France -- Reportlinker.com announces that a new market research report related to the worldwide pharmaceutical market is now available to its catalogue.
Pipeline and Commercial Insight: Influenza Vaccines - Pandemic threat revitalizes the sector
http://www.reportlinker.com/p048370/influenza-vaccines.html
Introduction
The influenza vaccine market, sized at approximately $2.2 billion in 2006, yields many challenges. Demand is highly variable, and only large players are able to cope with the need for annual updates and the costly manufacturing process. However, driven by the increasing pandemic threat, the market is growing fast and is predicted to more than double in size by 2016.
Scope
Strategic analysis of the current influenza market across the US, Japan, France, Germany, Italy, Spain and the UK and of key companies in the sector Thorough assessment of underlying commercial and clinical influencers shaping the influenza vaccine market Patient-based forecasts for the influenza vaccine market taking into account recommended vaccination groups and coverage rates in the 7 major markets In-depth comparative analysis of both seasonal and pandemic influenza vaccine pipeline candidates and discussion of their future potential
Highlights
The demand for influenza vaccines is highly variable and the time window for the vaccination is limited to just a few months per year. This, in combination with the need for annual updates and the long planning cycles required due to the lengthy egg-based manufacturing process, makes the flu vaccine market a highly challenging sector. The pandemic threat has acted as an important driver for the seasonal vaccine market. Rising…
Source: HighBeam Research, Examine the Worldwide Influenza Vaccine Market: Market Trends, Key...